KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 37,891 Value ($000) $506 Avg Close $13.50 Range $9.12 - $15.40
Q1 2025
Shares 115,518 Value ($000) $1,177 Avg Close $11.61 Range $9.71 - $16.70
Q4 2024
Shares 50,897 Value ($000) $806 Avg Close $51.97 Range $15.33 - $72.37
Q3 2024
Shares 24,752 Value ($000) $1,437 Avg Close $49.39 Range $40.93 - $59.06
Q2 2024
Shares 22,453 Value ($000) $1,026 Avg Close $53.73 Range $43.30 - $67.30
Q1 2024
Shares 17,053 Value ($000) $1,129 Avg Close $59.30 Range $39.00 - $73.00
Q4 2023
Shares 14,112 Value ($000) $561 Avg Close $31.36 Range $27.02 - $41.92
Q3 2023
Shares 60,341 Value ($000) $1,924 Avg Close $37.33 Range $31.17 - $44.95
Q2 2023
Shares 55,341 Value ($000) $2,224 Avg Close $43.84 Range $37.03 - $51.16
Q1 2023
Shares 45,484 Value ($000) $1,942 Avg Close $50.51 Range $39.98 - $59.96
Q3 2022
Shares 33,321 Value ($000) $1,254,000 Avg Close $34.66 Range $26.34 - $42.15
Q2 2022
Shares 57,321 Value ($000) $1,584,000 Avg Close $43.88 Range $24.38 - $68.29